Adam Rose, MD, MSc, an assistant professor of medicine at Boston University School of Medicine (BUSM), has accepted the Society of General Internal Medicine's (SGIM) New England Region 2011 Clinician Investigator Award for his contributions to quality of care research. The award was presented to Rose at the Society's New England Regional Meeting on March 4, 2011.
SGIM works to promote research and education that aims at improving healthcare for the whole patient and ensuring that all adults receive quality health care. The Clinician Investigator Award honors outstanding career achievements by a clinician-investigator in his or her first five years as a faculty member.
Rose's research has focused primarily on measuring quality of care for patients, particularly in the area of anticoagulation care to prevent strokes and other adverse events. In a study entitled "Using Risk-Adjusted Percent Time in Therapeutic Range as a Quality Indicator" Rose and colleagues found that quality of care varied wildly between hospitals for patients receiving oral anticoagulation in the Veterans Health Administration (VA). At some, patients spent only 40 percent of their stay in the desired therapeutic range, while at others they spent up to 70 percent of the time in that range.
"It is particularly meaningful for me to be recognized by SGIM, which has been my professional 'home' for years," said Rose. "As a researcher, I am driven by a strong desire to help as many patients as possible, so raising the visibility of this work is especially welcome."
Rose hopes that recognition of his work will prompt other organizations to consider ongoing measurement of anticoagulation control. In the future he plans to use the data he has collected to improve anticoagulation care for veterans.